SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹234 Cr | ₹204 Cr | ₹200 Cr | ₹16,826,961 Cr | ₹167 Cr |
What is the latest Total Expenditure of SYNCOM FORMULATIONS (INDIA) ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹234 Cr |
| Mar2024 | ₹204 Cr |
| Mar2023 | ₹200 Cr |
| Mar2022 | ₹16,826,961 Cr |
| Mar2017 | ₹167 Cr |
How is Total Expenditure of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹234 Cr | 14.38 | |
| Mar2024 | ₹204 Cr | 2.37 | |
| Mar2023 | ₹200 Cr | -100.00 | |
| Mar2022 | ₹16,826,961 Cr | 10,062,186.55 | |
| Mar2017 | ₹167 Cr | - | |
Compare Total Expenditure of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,166.5 Cr | 1.2% | -9.5% | -22.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,855.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,550.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,906.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,632.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,427.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 1.2% |
-9.5% |
-22.2% |
| SENSEX | -2.9% |
-8% |
5.3% |
You may also like the below Video Courses